Pharmacogenomics Using Artificial Intelligence
Optimizing Drug Response through Personalized Genomic Analysis
By John Wiley & Sons | Publisher: Wiley
About the book
Bridging the critical gap between complex genomic data and actual clinical practice, this essential volume delivers the cutting-edge AI methodologies, expert bioinformatics insights, and practical case studies needed to unlock truly personalized medicine.
The intersection of artificial intelligence and pharmacogenomics represents a transformative change in the life sciences industry. Pharmacogenomics, the study of how genetic variations influence an individual’s response to drugs, has long held the promise of enabling personalized treatments that are tailored to the genetic profile of individual patients, improving therapeutic outcomes and minimizing adverse drug reactions. However, the complexity of genomic data, massive scale of information, and challenge of interpreting the intricate relationships between genetic variations and drug responses have impeded the widespread implementation of personalized treatments in clinical practice. This volume explores how AI technologies are transforming personalized medicine by optimizing drug responses based on individual genetic profiles. The book will provide a comprehensive look at the role of AI in advancing pharmacogenomic research and its application in clinical practice, enabling healthcare professionals to predict the most effective and safest drugs for individual patients.
The book will be structured around the application of cutting-edge AI techniques in analyzing genomic data. Each chapter will highlight different aspects of AI-driven pharmacogenomics, from drug development and genetic variant identification to clinical implementation and ethical considerations. Experts from diverse fields, including bioinformatics, pharmacology, and data science, will contribute insights into how AI can be harnessed to analyze large genomic datasets, predict patient-specific drug responses, and overcome existing challenges in precision medicine. This volume will not only provide theoretical knowledge but also offer practical examples, case studies, and methodologies that researchers, clinicians, and healthcare professionals can utilize to enhance pharmacogenomic research and personalize patient care.
Editions of Pharmacogenomics Using Artificial Intelligence
- Hardcover
- ISBN 9781394404438
- EBook
- ISBN 9781394404469
- EBook
- ISBN 9781394404452
- EBook
- ISBN 9781394404445
Read an Excerpt
Bridging the critical gap between complex genomic data and actual clinical practice, this essential volume delivers the cutting-edge AI methodologies, expert bioinformatics insights, and practical case studies needed to unlock truly personalized medicine.
The intersection of artificial intelligence and pharmacogenomics represents a transformative change in the life sciences industry. Pharmacogenomics, the study of how genetic variations influence an individual’s response to drugs, has long held the promise of enabling personalized treatments that are tailored to the genetic profile of individual patients, improving therapeutic outcomes and minimizing adverse drug reactions. However, the complexity of genomic data, massive scale of information, and challenge of interpreting the intricate relationships between genetic variations and drug responses have impeded the widespread implementation of personalized treatments in clinical practice. This volume explores how AI technologies are transforming personalized medicine by optimizing drug responses based on individual genetic profiles. The book will provide a comprehensive look at the role of AI in advancing pharmacogenomic research and its application in clinical practice, enabling healthcare professionals to predict the most effective and safest drugs for individual patients.
The book will be structured around the application of cutting-edge AI techniques in analyzing genomic data. Each chapter will highlight different aspects of AI-driven pharmacogenomics, from drug development and genetic variant identification to clinical implementation and ethical considerations. Experts from diverse fields, including bioinformatics, pharmacology, and data science, will contribute insights into how AI can be harnessed to analyze large genomic datasets, predict patient-specific drug responses, and overcome existing challenges in precision medicine. This volume will not only provide theoretical knowledge but also offer practical examples, case studies, and methodologies that researchers, clinicians, and healthcare professionals can utilize to enhance pharmacogenomic research and personalize patient care.
Frequently Asked Questions
What is Pharmacogenomics Using Artificial Intelligence about?
Bridging the critical gap between complex genomic data and actual clinical practice, this essential volume delivers the cutting-edge AI methodologies, expert bioinformatics insights, and practical case studies needed to unlock truly personalized medicine.
The intersection of artificial intelligence and pharmacogenomics represents a transformative change in the life sciences industry. Pharmacogenomics, the study of how genetic variations influence an individual’s response to drugs, has long held the promise of enabling personalized treatments that are tailored to the genetic profile of individual patients, improving therapeutic outcomes and minimizing adverse drug reactions. However, the complexity of genomic data, massive scale of information, and challenge of interpreting the intricate relationships between genetic variations and drug responses have impeded the widespread implementation of personalized treatments in clinical practice. This volume explores how AI technologies are transforming personalized medicine by optimizing drug responses based on individual genetic profiles. The book will provide a comprehensive look at the role of AI in advancing pharmacogenomic research and its application in clinical practice, enabling healthcare professionals to predict the most effective and safest drugs for individual patients.
The book will be structured around the application of cutting-edge AI techniques in analyzing genomic data. Each chapter will highlight different aspects of AI-driven pharmacogenomics, from drug development and genetic variant identification to clinical implementation and ethical considerations. Experts from diverse fields, including bioinformatics, pharmacology, and data science, will contribute insights into how AI can be harnessed to analyze large genomic datasets, predict patient-specific drug responses, and overcome existing challenges in precision medicine. This volume will not only provide theoretical knowledge but also offer practical examples, case studies, and methodologies that researchers, clinicians, and healthcare professionals can utilize to enhance pharmacogenomic research and personalize patient care.
What core themes, tropes, or subjects are explored in Pharmacogenomics Using Artificial Intelligence?
Medicine and Nursing > Medical specialties, branches of medicine > Pharmacology
Where can I read a sample of Pharmacogenomics Using Artificial Intelligence?
You can read an official preview of the few pages here https://www.book2look.com/book/9781394404438
Who is/are the Author/s of the book Pharmacogenomics Using Artificial Intelligence?
John Wiley & Sons
Who is the Publisher of the book Pharmacogenomics Using Artificial Intelligence?
Wiley
What are the ISBN numbers for the physical and digital editions?
Pharmacogenomics Using Artificial Intelligence is available as hardcover(ISBN 9781394404438) and ebook(ISBN 9781394404469) and ebook(ISBN 9781394404452) and ebook(ISBN 9781394404445)
Where can I buy Pharmacogenomics Using Artificial Intelligence online or support local independent bookshops?
You can buy Pharmacogenomics Using Artificial Intelligence from below
Where can I buy Pharmacogenomics Using Artificial Intelligence?